semaglutide schizophrenia in Patients With Schizophrenia, Prediabetes, and Obesity ๐จ 1. Semaglutide significantly improved insulin sensitivity, reduced insulin resistance, lowered fasting glucose, and promoted substantial weight loss in patients with antipsychotic ๐ฆ๐ฒ๐บ๐ฎ๐ด๐น๐๐๐ถ๐ฑ๐ฒ ๐ถ๐ป ๐ฆ๐ฐ๐ต๐ถ๐๐ผ๐ฝ๐ต๐ฟ๐ฒ๐ป๐ถ๐ฎ: JAMA Psychiatry
Pay in 4 interest-free payments of $5.60 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours ยท Estimated delivery Aug 4 - Aug 9





























